Who owns INDAPTUS THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Indaptus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Indaptus Therapeutics stock

Who bought or sold INDAPTUS THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 256k $574k 0% Mar 2024
 View chart
Investment House 102k $230k 0% Mar 2024
 View chart
Geode Capital Management 55k $123k 0% Mar 2024
 View chart
Strategy Asset Managers 45k $102k 0% Mar 2024
 View chart
Pine Valley Investments Ltd Liability 44k $99k 0% Mar 2024
 View chart
Vivaldi Capital Management 24k $52k 0% Mar 2024
 View chart
Tower Research Capital 4.1k $9.1k 34% Mar 2024
 View chart
UBS Group 1.9k $4.3k -48% Mar 2024
 View chart
Morgan Stanley 884.00 $2.0k -14% Mar 2024
 View chart
Bangor Savings Bank 400.00 $896.000000 0% Mar 2024
 View chart
Wells Fargo & Company 105.00 $235.609500 1% Mar 2024
 View chart
Jpmorgan Chase & Co 14.00 $31.000200 56% Mar 2024
 View chart
Group One Trading 7.00 $15.999900 0% Mar 2024
 View chart
Qube Research & Technologies 1.00 $2.000000 0% Mar 2024
 View chart

Who sold out of Indaptus Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Citadel Advisors Dec 2023 17k $29k
Royal Bank of Canada Dec 2023 38.00 $0
Bank of America Corporation Dec 2023 3.00 $5.000100